¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"compound lipid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°
  • closed-chain compound
    ´ÝÈù»ç½½È­ÇÕ¹°
  • complex compound
    º¹ÇÕÈ­ÇÕ¹°
  • compound
    1. È­ÇÕ¹° 2. º¹ÇÕ
  • compound astigmatism
    º¹ÇÕ³­½Ã
  • compound dislocation
    º¹ÀâÅ»±¸
  • compound fracture
    º¹ÇÕ°ñÀý, °³¹æ°ñÀý
  • compound gland
    º¹ÇÕ»ù, º¹ÇÕ¼±
  • compound heterozygote
    º¹ÇÕÀÌÇüÁ¢ÇÕÀÚ
  • compound joint
    º¹ÇÕ°üÀý
  • compound lens
    º¹ÇÕ·»Áî
  • compound lens microscope
    º¹ÇÕ·»ÁîÇö¹Ì°æ
  • compound monster
    ÀϹݺ¹Ã¼±âÇü
  • compound muscle action potential
    º¹ÇÕ±Ù(À°)Ȱµ¿ÀüÀ§
  • compound nerve action potential
    º¹ÇսŰæÈ°µ¿ÀüÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°
  • asymmetric compound
    ºñ´ëĪȭÇÕ¹°
  • compound astigmatism
    º¹ÇÕ³­½Ã
  • compound
    º¹Àâ, º¹ÇÕ, È­ÇÕ¹°
  • chain compound
    »ç½½È­ÇÕ¹°
  • complex compound
    º¹ÇÕÈ­ÇÕ¹°
  • compound dislocation
    º¹ÀâÅ»±¸
  • compound fracture
    º¹Àâ°ñÀý, °³¹æ°ñÀý
  • compound gland
    º¹ÇÕ»ù
  • compound joint
    º¹ÇÕ°üÀý
  • compound lens
    º¹ÇÕ·»Áî
  • compound monster
    ÀϹݺ¹Ã¼±âÇü
  • compound nevus
    º¹ÇÕ¸ð¹Ý
  • compound presentation
    º¹ÇÕÅÂÀ§
  • compound scan
    º¹ÇÕ½ºÄµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heteropolar compound
    ÀÌ(¼º)±ØÈ­ÇÕ¹°(ì¶àõпûùùêÚª).
  • homeopolar compound
    µ¿±ØÈ­ÇÕ¹°.
  • homocyclic compound
    µ¿¼Òȯ½ÄÈ­ÇÕ¹°.
  • homopolar compound
    µ¿±ØÈ­ÇÕ¹°(ÔÒпûùùêÚª).
  • impression compound
    Àλó¿ë ÄÄÆÄ¿îµå.
  • inorganic compound
    ¹«±âÈ­ÇÕ¹°.
  • polyfunctional compound
    ´Ù°ü´ÉÈ­ÇÕ¹°(ÒýίÒöûùùêÚª).
  • quaternary compound
    »ç¿øÈ­ÇÕ¹°(ÞÌêªûùùêÚª).
  • racemic compound
    ·¹À̼¼¹ÌÈ­ÇÕ¹°.
  • radioactive luminous compound
    ¹æ»ç¼º¹ß±¤È­ÇÕ¹°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lipid metabolism
    ÁöÁú´ë»ç(¡­ÓÛÞó).
  • lipid myopathy
    Áö¹æ±Ùº´Áõ(¡­ÐÉÜ»ñø)
  • lipid peroxidation
    ÁöÁú °ú»êÈ­(¡­Î¦ß«ûù)
  • lipid pneumonia
    ÁöÁúÆó·Å(ò·òõøËæú).
  • lipid pneumonia
    ÁöÁúÆó·Å(ò·òõøËæú)
  • lipid proteinosis
    ÁöÁú´Ü¹éÁõ(¡­Ó±ÛÜñø).
  • lipid solubility
    ÁöÁú¿ëÇØµµ, Áö¿ë¼º.
  • lipid storage disease
    ÁöÁúÃàÀûÁõ
  • lipid storage disease
    ÁöÁúÃàÀûÁõ.
  • lipid transport
    ÁöÁú¿î¼Û
  • lipid-soluble drug
    Áö¿ë¼º¾à¹°
  • lipid/lipoprotein
    ÁöÁú/Áö´Ü¹é
  • lipid/lipoprotein level
    ÁöÁú/Áö´Ü¹é Ä¡(°ª)
  • acyclic compound
    ºñȯ»óÈ­ÇÕ¹°.
  • addition compound
    ÷°¡È­ÇÕ¹°(ôÕÊ¥ ûùùêÚª).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • low-energy compound
    Àú(î¸)¿¡³ÊÁöÈ­ÇÕ¹°(ûùùêÚª)
  • meso compound
    ¸Þ¼ÒÈ­ÇÕ¹°(ûùùêÚª)
  • nodal compound
    ¿ËÀÌ È­ÇÕ¹°(ûùùêÚª)
  • prochiral compound
    ۶ö Àü±¸È­ÇÕ¹°(îñÏÌûùùêÚª)
  • quaternary ammonium compound
    »çÂ÷(ÞÌó­) ¾Ï¸ð´Ï¾ÆÈ­ÇÕ¹°(ûùùêÚª).
  • Reichstein's compound
    ¶óÀÌÅ©½ºÅ¸ÀÎ È­ÇÕ¹°(ûùùêÚª)
  • van der Waals compound
    ¹Ý µ§ ¹ß½º È­ÇÕ¹°(ûùùêÚª)
  • bare lipid membrane
    ¾Ë¸ö ÁöÁú¸·(ò·òõد)
  • bilayer lipid membrane
    ¾çÃþ ÁöÁú¸·(å»öµ ò·òõد)
  • bimolecular lamellar lipid membrane
    À̺ÐÀÚ(ì£ÝÂí­) ÆÇ»óÁöÁú¸·(÷ùßÒò·òõد)
  • bimolecular lipid membrane
    À̺ÐÀÚ ÁöÁú¸·(ì£ÝÂí­ò·òõد)
  • black lipid membrane
    Èæ ÁöÁú¸·(ýÙò·òõد)
  • C55 lipid carrier
    "C55 ÁöÁú¿î¹Ýü(ò·òõê¡Úæô÷),(ÔÒ) bactoprenol"
  • complex lipid
    º¹ÇÕÁöÁú(ÜÜùêò·òõ)
  • derived lipid
    À¯µµÁöÁú(ë¯Óôò·òõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
INLSD ichthyosis and neutral lipid storage disease
LB lamellar body; large bowel; left breast; left bronchus; left bundle; left buttock; leiomyoblastoma; ...
LBSA lipid-bound sialic acid
LC Laennec cirrhosis; Langerhans cell; late clamped; large chromophobe; lecithin cholesterol acyltransf...
LCC lactose coliform count; left circumflex coronary (artery); left common carotid; left coronary cusp; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
OP organophosphorus compound
OLC Ouabainlike compound
OPIDN organophosphorous compound-induced delayed neurotoxicity
MLA 4'-Monophosphoryl lipid A
ALBP Adipocyte lipid binding protein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • compound gland
    º¹ÇÕ »ù, º¹ÇÕ¼±
    ºÐºñ °üÀÌ °¡Áö¸¦ ³½´Ù. ºÐºñ ´ÜÀ§´Â È¥ÇÕÇüÀ¸·Î, °ü»ó Æ÷»ó »ùÀ̶ó´Â ¿ë¾î°¡ »ç¿ëµÈ´Ù.
  • compound nevus
    º¹ÇÕ¼º ¸ð¹Ý, º¹ÇÕ ¸ð¹Ý
  • compound S
    º¹ÇÕü S
  • compound scan motion
    º¹ÇÕ ½ºÄµ ¿îµ¿
  • compound specificity
    È­ÇÕ¹° ƯÀ̼º
  • hydrated compound
    ¼öÈ­ È­ÇÕ¹°
  • impression compound
    Àλó¿ë ÄÞÆÄ¿îµå
    Àλó¿ë°ú Æ®·¹ÀÌ¿ëÀÌ ÀÖ°í, õ¿¬ ¼öÁö, ÇÕ¼º ¼öÁö µîÀ¸·Î µÇ¾î ¿­ °¡¼Ò¼ºÀ» °®´Â ÀλóÀç.
  • inorganic compound
    ¹«±â È­ÇÕ¹°
    ź¼Ò¸¦ Æ÷ÇÔÇÏÁö ¾Ê´Â È­ÇÕ¹°.
  • intermetallic compound
    ±Ý¼Ó°£ È­ÇÕ¹°
    ¼ººÐ ¿ø¼Ò°¡ °£´ÜÇÑ Á¤¼öºñ·Î °áÇÕÇϰí ÀÖ´Â ÇÕ±Ý.
  • modeling compound impression
    ¿¬¼ºÀç Àλó
  • molecular compound
    ºÐÀÚ È­ÇÕ¹°
  • moulding compound impression
    ¿¬¼ºÀç Àλó
  • open chain compound
    ¿­¸° »ç½½ È­ÇÕ¹°
  • organometallic compound
    À¯±â ±Ý¼Ó È­ÇÕ¹°
    À¯±â ±â¿Í °áÇÕµÈ ±Ý¼ÓÀ¸·Î ÀÌ·ç¾îÁø È­ÇÕ¹°.
  • paraffin compound
    ÆÄ¶óÇÉÁ· È­ÇÕ¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
lipid granulomatosis <dermatology, pathology> An accumulation of an excess of lipids in the body due to disturbance of lipid metabolism and marked by the formation of foam cells in skin lesions.
(16 Dec 1997)
lipid histiocytosis Histiocytosis with cytoplasmic accumulation of lipid, either phospholipid (Niemann-Pick disease) or glucocerebroside (Gaucher's disease).
(05 Mar 2000)
lipid keratopathy Occurrence of fats in an area of corneal vascularization.
(05 Mar 2000)
lipid mobilization The breakdown of stored triglyceride in adipose tissue with the release of free fatty acids and glycerol. Depot fat hydrolysis is catalyzed by a lipase in response to pituitary lipid mobilization factors (lmf), various hormones, serotonin, or hepatotoxins such as carbon tetrachloride.
(12 Dec 1998)
lipid-mobilizing hormone <protein> Polypeptide hormone (_ form: 9894D, 91 residues, _ form has only residues 1-58 of _) from the pituitary hypophysis, that is of particular interest because it is the precursor of endorphins, which are released by proteolysis. Promotes lipolysis and acts through the adenylyl cyclase system. Part of the ACTH group of hormones.
(18 Nov 1997)
lipid peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor.
(12 Dec 1998)
lipid peroxides Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin e, structural separation or low oxygen tension.
(12 Dec 1998)
lipid pneumonia Lipoid pneumonia, pulmonary condition marked by inflammatory and fibrotic changes in the lungs due to the inhalation of various oily or fatty substances, particularly liquid petrolatum, or resulting from accumulation in the lungs of endogenous lipid material, either cholesterol from obstructive pneumonitis or following fracture of a bone; phagocytes containing lipid are usually present.
Synonym: oil pneumonia.
(05 Mar 2000)
lipid profile Pattern of lipids in the blood. (A lipid profile usually includes the total cholesterol, high density lipoprotein (hdl) cholesterol, triglycerides, and the calculated low density lipoprotein (ldl) cholesterol.
(12 Dec 1998)
lipid storage diseases A series of disorders due to inborn errors in lipid metabolism resulting in the abnormal accumulation of lipids in the wrong places (examples include gaucher, fabry and niemann-pick diseases and metachromatic leukodystrophy).
(12 Dec 1998)
acetone compound <biochemistry> Any of the three compounds created by acetyl coenzyme A (acetoacetate, hydroxybutyrate, and acetone) which are water-soluble cellular fuels normally exported by the liver.
They can build up in the blood and body tissues because of starvation, untreated diabetes mellitus, or other disorders that interfere with carbohydrate metabolism. The body rids itself of ketones mainly through urine, but it rids itself of acetone through the lungs, which gives the breath a characteristic fruity odour. If ketones build up in the body long enough, they cause serious illness and coma (see ketoacidosis.)
(09 Oct 1997)
acyclic compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
addition compound Strictly, a complex of two or more complete molecules in which each preserves its fundamental structure and no covalent bonds are made or broken (e.g., hydrates of salts, adducts), loosely, association of acids with basic organic compound's (e.g., amines with HCl), more loosely, addition of two molecules without loss of any atom, but forming new covalent bonds (e.g., CH2==CH2 + Br2 &rarr; BrCH2-CH2Br).
(05 Mar 2000)
aliphatic compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
APC compound An analgesic tablet drug combination containing aspirin, phenacetin and caffeine. Very widely used in the 1940's through 1960's; original constituents of popular over-the-counter pain remedies. Use currently much diminished due to concerns about potential renal injury due to the phenacetin.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • compound number
    Á¦µî¼ö(µÑÀÌ»óÀÇ ´ÜÀ§·Î Ç¥½ÃµÇ´Â ¼ö)
  • compound personal pronoun
    º¹ÇÕ ÀÎĪ ´ë¸í»ç(ÀÎĪ ´ë¸í»ç µÚ¿¡ -self°¡ ºÙÀº °Í)
  • compound relative
    º¹ÇÕ°ü°è»ç
  • compound sentence
    Áß¹®(ÀýÀ» and,butµî µîÀ§ Á¢¼Ó»ç·Î ÀÌÀº ¹®Àå)
  • compound word
    º¹ÇÕ¾î;ÇÕ¼º¾î
  • compound-complex sentence
    Áߺ¹¹®(Á¾¼ÓÀýÀ» ÇϳªÀÌ»ó °¡Áø Áß¹®)
  • interstitia compound
    È­ ħÀÔÇüÈ­ÇÕ¹°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á